Examination of the effect of ingection of the test food on cholesterol metabolism, BMI, and body fat.

Examination of the effect of ingection of the test food on cholesterol metabolism, BMI, and body fat. - Examination of the effect of the test food on cholesterol metabolism, BMI, and body fat.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038650

Enrollment

Registered

2019-11-22

Start date

2019-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Oral ingestion of 4 capsules of test food 1 daily for 24 weeks. Oral ingestion of 4 capsules of test food 2 daily for 24 weeks. Oral ingestion of 4 placebo capsules daily for 24 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals who can understand the purpose and contents of this study and can agree to participate in this study by letter. 2. Individuals whose BMI is >=23 and <30 kg/m2. 3. Individuals whose internal organ fat level is less than 10 on a body composition meter. 4. Individuals whose fasting blood test results are blood glucose <126 mg/dL, low-density lipoprotein cholesterol <140 mg/dL, alanine transaminase <=45, and aspartate transaminase <=40.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will not be selected as study subjects: 1. Pregnant and nursing mothers, and individuals with a desire to become pregnant during the study period 2. Individuals taking medication on a routine basis 3. Individuals who are taking foods for specific health use, foods with function claims, and/or health foods, in the case that such foods affect blood lipid levels or blood sugar level. 4. Individuals with gelatin allergy. 5. Individuals with inflammatory bowel disease 6. Other individuals deemed unsuitable by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Body Mass Index(BMI) Body fat percentage Blood LDL-Cholesterol	—

Secondary

Measure	Time frame
Blood glucose level ALT, AST Insulin HbA1c Adiponectin	—

Countries

Japan

Contacts

Public ContactShunji Mizobuchi

Kochi Medical School, Kochi University Clinical nursing

mizoshun@kochi-u.ac.jp088-866-5811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026